| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000008301 |
| Receipt No. | R000009213 |
| Official scientific title of the study | A Prospective Single-Center Observational study of the Safety and Performance of the Vessel Sealing System (LigaSure) in a Pulmonary Resection |
| Date of disclosure of the study information | 2012/07/01 |
| Last modified on | 2018/08/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A Prospective Single-Center Observational study of the Safety and Performance of the Vessel Sealing System (LigaSure) in a Pulmonary Resection | |
| Title of the study (Brief title) | A Prospective Single-Center Observational study of the Safety and Performance of the Vessel Sealing System (LigaSure) in a Pulmonary Resection | |
| Region |
|
|
| Condition | ||
| Condition | Lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine and evaluate the safety and performance of the LigaSure vessel sealing system for processing pulmonary arteries in patients scheduled to undergo pulmonary resection |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The success rate and results of sealing of pulmonary arteries (under 5 mm in diameter) |
| Key secondary outcomes | The frequency of additional procedures to the sealed sites during surgery. The occurrence frequency of intraoperative and postoperative adverse events, the duration of drain placement, and the duration of hospitalization. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients in whom LigaSure may be used during such surgery as pulmonary lobectomy and pulmonary segmentectomy
2)Patients aged 20 years or older 3)Patients scheduled to undergo pulmonary lobectomy and pulmonary segmentectomy 4)Patients with ECOG Performance Status 0 to 1 5)Patients with no history of ipsilateral open lung surgery 6)Patients with preserved major organ function 7)Patients who have provided written informed consent for participation in the study |
|||
| Key exclusion criteria | 1)Patients with a history of chest injury or pulmonary lobectomy
2)Patients with non-curative resectable factors of pulmonary cancer such as pleural dissemination and malignant pleural effusion on opening the chest 3)Patients with active bacterial and/or fungal infections 4)Patients receiving continued systemic (oral or intravenous) steroids 5)Patients with uncontrolled diabetes mellitus (HbA1c > 8.0%) 6)Patients with impaired major organ function (CTCAE ver. 4.0 Grade ≥ 2) 7)Patients with a psychiatric disorder or psychiatric symptoms that would preclude participation in the study 8)Any other patients judged by the doctor in charge to be ineligible as subjects in the study |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Norihiko Ikeda |
| Organization | Tokyo Medical University |
| Division name | First Department of Surgery |
| Address | 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo |
| TEL | |
| Public contact | |
| Name of contact person | |
| Organization | Tokyo Medical University |
| Division name | First Department of Surgery |
| Address | |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | First Department of Surgery, Tokyo Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Covidien Japan inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | A prospective single-arm single-center observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000009213 |